Thailand Vertical Farming & Indoor Ag 2027 Market Intelligence
Thai controlled-environment agriculture and indoor vertical-farm footprint stepped from ~5-8 sites in 2020 to ~25-40 in 2024; 2027 thesis lifts the market from THB 0.8-1.4B to THB 4-7B as BOI Section 8, FDA cannabis medical-grow, and PTT, B.Grimm captive bays compound.
Key takeaways
- 1
Thai controlled-environment agriculture (CEA) and indoor vertical-farm footprint stepped from an estimated 5-8 commercial sites in 2020 to 25-40 in 2024. Insight base case carries the market from an estimated 2024 toward by 2027 on the BCG bio-circular-green policy stack, BOI Section 8 incentives, FDA medical-cannabis licensing, and direct-to-consumer brand build.
- 2
Policy stack: BOI Section 8 promoted activities offer up to five years of corporate tax holiday plus import-duty exemption on hydroponic and LED equipment; the BCG bio-circular-green economy model (NXPO 2021-2027 strategy) anchors CEA as a priority cluster.
- 3
Anchor operators: Wongnok Farm Tech, Thai Farming Tech, NongPlus AgriTech (PTT NRPT partner), PTT NRPT industrial-estate captive bays, B.Grimm AgriTech Amata pilot, UrbanBuoy and Tama Farm Bangkok direct-to-consumer, Habiterre Chiang Mai, Royal Project Foundation highland research plots.
- 4
Cannabis medical-grow recriminalisation in 2025 redirects indoor-grow capex into FDA GAP and GMP licensed facilities. Insight estimates 80-120 active operations in 2024, projecting 250-350 by 2027; the segment captures roughly of 2027 CEA revenue.
- 5
Our 2027 read: CEA scales as a credentialed premium-produce and medical-grow play, gated by Ft electricity tariff trajectory, FDA licence cadence, and the imported LED, nutrient-automation cost-down curve from Heliospectra, Signify and Priva.
Executive summary
Thailand's controlled-environment agriculture and indoor vertical-farming layer is one of the country's more credentialed but still under-measured agtech segments. Insight estimates roughly 25-40 commercial sites operating in 2024, up from an estimated 5-8 in 2020. Headline revenue sits at an estimated in 2024, derived from BOI Section 8 promoted-investment disclosures, operator press, the NSTDA BIOTEC Pathum Thani pilot scale, and a Thai-share take on the Grand View Research global vertical-farming benchmark ( in 2024 to by 2030 at ~ CAGR).[, , , ]
The 2027 catalyst stack is unusually dense. BOI Section 8 promoted activities under the BCG bio-circular-green economy model carry up to a five-year corporate income tax holiday and import-duty exemption on hydroponic equipment, LED horticulture lighting and nutrient-dosing automation. NSTDA BIOTEC operates a plant-factory pilot at Thailand Science Park in Pathum Thani that hands functional-food, medicinal-plant and high-value-vegetable bays to commercial partners. PTT Group's NRPT (Nature Reserve Plant Technology) joint venture with NongPlus AgriTech, and B.Grimm Power's AgriTech captive pilot at Amata Industrial Estate, signal that listed Thai energy and industrial groups treat CEA as both a downstream offtake play and a green-credential capex line.[, , , ]
The thesis: by 2027 the headline Thai CEA and indoor vertical-farm market reaches , an Insight base case roughly 3.5x the 2024 anchor. The mix is bifurcated. FDA cannabis medical-grow specialists, recapitalised after the 2025 recriminalisation of recreational use, capture an estimated of revenue on a base case of roughly 250-350 GAP and GMP licensed operations (versus 80-120 in 2024). Commercial leafy-green, herb, microgreen, strawberry-tunnel and direct-to-consumer subscription operators capture the remainder. The binding 2027 variables are electricity tariff trajectory (the Ft formula), FDA licence cadence, and the cost-down curve on imported Heliospectra, Signify Philips and Priva equipment, which penetrate roughly of new commercial builds.[, , , , ]
Thai CEA and indoor vertical-farm market size (THB billion, 2020-2027F)
2020
Revenue (THB B)
~0.4
Facilities
~5-8
Context
Pre-policy: pilot pods, Royal Project highland tunnels, early hydroponic
2021
Revenue (THB B)
~0.6
Facilities
~8-12
Context
BCG model announced; early BOI Section 8 promoted projects
2022
Revenue (THB B)
~0.9
Facilities
~12-18
Context
Cannabis decriminalisation drives indoor-grow capex
2023
Revenue (THB B)
~1.1
Facilities
~18-25
Context
Wongnok, Thai Farming Tech, UrbanBuoy commercial scale
2025E
Revenue (THB B)
~2.1
Facilities
~45-65
Context
Cannabis recriminalisation redirects capex to FDA medical-only
2026E
| Year | Revenue (THB B) | Facilities | Context |
|---|---|---|---|
| 2020 | ~0.4 | ~5-8 | Pre-policy: pilot pods, Royal Project highland tunnels, early hydroponic |
| 2021 | ~0.6 | ~8-12 | BCG model announced; early BOI Section 8 promoted projects |
| 2022 | ~0.9 | ~12-18 | Cannabis decriminalisation drives indoor-grow capex |
| 2023 | ~1.1 | ~18-25 | Wongnok, Thai Farming Tech, UrbanBuoy commercial scale |
| 2024 | ~1.3 | ~25-40 | PTT NRPT, B.Grimm AgriTech captive pilots launch |
| 2025E | ~2.1 | ~45-65 | Cannabis recriminalisation redirects capex to FDA medical-only |
| 2026E | ~3.4 | ~80-110 | BIOTEC pilot hand-off; medical-grow licensees compound |
| 2027F | ~5.2 | ~140-190 | Base case: $0.116-7B; medical-grow ~40-50% share |
End-use revenue mix (% of 2026E CEA market)
Cannabis medical-grow GAP, GMP licensed
Share %
Notes
Pharmaceutical-input pricing absorbs high kWh per kg; FDA-gated
Leafy greens (lettuce, kale, mizuna)
Culinary herbs (basil, mint, coriander)
Share %
Notes
HORECA, premium retail; smaller volume, higher gross margin
Microgreens
Share %
7%
Notes
Bangkok restaurants, hotel breakfast buffets, D2C subscription brands
Strawberry tunnels and high-value produce
Share %
9%
Notes
Royal Project highland tunnels, polytunnel CEA hybrid, premium hampers
Other (functional herbs, edible flowers, seedlings)
Share %
5%
Notes
BIOTEC research bays, specialty wellness, seedling propagation
| End-use segment | Share % | Notes |
|---|---|---|
| Cannabis medical-grow GAP, GMP licensed | 45% | Pharmaceutical-input pricing absorbs high kWh per kg; FDA-gated |
| Leafy greens (lettuce, kale, mizuna) | 22% | Modern-trade premium retail, HORECA, hotel cafeterias |
| Culinary herbs (basil, mint, coriander) | 12% | HORECA, premium retail; smaller volume, higher gross margin |
| Microgreens | 7% | Bangkok restaurants, hotel breakfast buffets, D2C subscription brands |
| Strawberry tunnels and high-value produce | 9% | Royal Project highland tunnels, polytunnel CEA hybrid, premium hampers |
| Other (functional herbs, edible flowers, seedlings) | 5% | BIOTEC research bays, specialty wellness, seedling propagation |
Analyst framing
Why this report
Unlock the full report
Need more than the web report? Ask for a scoped export or source appendix.
Every report keeps visible citations and source metadata. Terms.
Key figures
Selected anchors from the report evidence pack.
Thai CEA and vertical-farm market 2027F
Insight derivation from BOI Section 8, BIOTEC pilot, SCB EIC precision-ag outlook, Grand View global benchmark
Commercial CEA and vertical-farm sites 2024
Insight derivation from BOI Section 8 disclosures, operator press, BIOTEC pilot directory
FDA cannabis medical-grow GAP and GMP licensees 2024
Thai FDA narcotics directorate registry, DOA GAP manual
Medical-grow share of 2027 CEA market
Insight derivation from FDA licensee curve, BOI disclosures, operator triangulation
Imported LED share of new CEA builds
Signify case studies, Heliospectra disclosures, SCB EIC precision-ag outlook
kWh per kilogram leafy-green CEA benchmark
Insight derivation from operator disclosures, ERC tariff schedule, Priva and Signify CEA benchmarks
CapEx per square metre, multi-tier vertical CEA
Insight derivation from BOI Section 8 disclosures, operator press, Priva and Signify build benchmarks
BOI Section 8 corporate tax holiday for CEA
Thailand Board of Investment guide, NXPO BCG strategy
Related reports
Thailand Agritourism, Farm-Stay and Rural Wellness 2027 Market Intelligence
Thailand's agritourism, farm-stay and rural-wellness layer generates an estimated THB 6-9B in 2026, anchored by the GSTC-recognised CBT Thailand standard, DASTA's nine SOUL OF THAILAND routes, royal-project estates (Doi Tung, Doi Chaang), Chanthaburi-Rayong durian orchards, Mae Kampong forest-village and Sangkhlaburi Mon-Karen agroforestry. The 2027 thesis: rural revival reframed as soft-power and climate-adaptation, with Indian and ASEAN inbound packages turning village hospitality from charity case into margin segment.
Open report β
Thailand AI Enterprise Adoption 2027 Market Intelligence
Thai enterprise AI adoption sits at roughly 25-35% of SET-100 large corporates in 2026, still nascent compared with Singapore and Korea but accelerating. Three structural tailwinds carry the sector to 2027: hyperscaler GPU-cluster maturation (AWS Bangkok USD 5B+, Google Cloud USD 1B+ Chonburi, Microsoft's March 2026 GPU commitment), Thai-language vertical AI on Typhoon (SCB 10X open-weight) and NSTDA ThaiLLM, and the BOI Category 1.6, 1.7 incentive plus the AI Engineer Visa pipeline. Domestic studios (PandaAI, Botnoi, Sertis, AI Engineer Studio, BeyondX, Pyth) anchor document automation, customer service, fraud detection, and vertical knowledge retrieval. Report maps adoption tiers, compute layer mix, operator concentration, and 2027 scenarios.
Open report β
Thailand Cold-Pressed Juice & Functional Beverage 2027 Market Intelligence
Thailand's health and wellness beverage category generated an estimated THB 95-105B in 2026, anchored by Osotspa's 37 percent functional and 54.8 percent energy share, Carabao Group's carbonated vitamin line (up 26 percent YoY in 2024), TC Pharmaceutical's Sponsor (73.5 percent sports-drink share) and Yanhee's 32 percent vitamin-water lead, with an emerging premium tier of cold-pressed HPP juice (Fresher Kitchen Beep, License To Blend, MyJuiceBkk), kombucha (Fermenthe), and fortified plant-milk (Lactasoy, Dutch Mill). The 2027 thesis: sugar tax phase four (2025), the national 90 percent low-sugar consumer target by 2027, and the June 2025 cannabis recontrol together force the category from energy-drink mass into clean-label premium where HPP juice, probiotic and adaptogen formats earn structurally higher margins.
Open report β